GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (MIL:1MRK) » Definitions » Current Accrued Expense

Merck KGaA (MIL:1MRK) Current Accrued Expense : €0 Mil (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Merck KGaA Current Accrued Expense?

Merck KGaA's Current Accrued Expense for the quarter that ended in Sep. 2024 was €0 Mil.

Merck KGaA Current Accrued Expense Historical Data

The historical data trend for Merck KGaA's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Current Accrued Expense Chart

Merck KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Merck KGaA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Merck KGaA Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Merck KGaA Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (MIL:1MRK) » Definitions » Current Accrued Expense
Comparable Companies
XTER:EVT XTER:B8FK ZTS NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS HKSE:03692 SZSE:000538 NBIX NSE:TORNTPHARM BOM:543904 BOM:500124 TSE:4507 BOM:532321 BOM:500257
Traded in Other Exchanges
MKKGY:USA MKGAF:USA MRK1:Mexico MRKd:UK 0O14:UK MRK:Germany MRK:Bulgaria
Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Website
https://www.emdgroup.com
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA Headlines

No Headlines